PIRS

Pieris Pharmaceuticals, Inc.

NASDAQHealthcareBiotechnologyUS

USD13.60

-2.51 (-15.58%)

Company Profile

CEO

Stephen S. Yoder

IPO Date

2015-01-02

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

Country

Market Metrics

Open

$15.04

Prev. Close

$16.11

Day Low

$13.26

Day High

$15.35

52W Low

$6.20

52W High

$22.32

Market Cap

$0.02B

Volume

0.05M

News SentimentBullish

Articles

Avg Positive

59.3%

Avg Negative

2.2%

Avg Neutral

38.6%

News Feed

Pieris Pharmaceuticals to Host Second Quarter 2021 Investor Call and Provide Corporate Update on August 4, 2021

Accesswire·7/28/2021·↑ positive

Pieris Stock Moves Higher On €14.2M Grant For PRS-220 In Post-COVID Pulmonary Fibrosis

Benzinga·6/25/2021·↑ positive

Pieris Pharmaceuticals Announces Inhaled CTGF Inhibitor PRS-220 for Idiopathic Pulmonary Fibrosis and 17 Million Dollar Grant From Bavarian Government To Accelerate Program Development for Post-COVID-19 Pulmonary Fibrosis

Accesswire·6/25/2021·↑ positive